[Formation of a multicenter study conducted during the 1986 pollen season].
A multicentre study was conducted in France during the 1986 pollen season. 186 patients who were diagnosed as suffering from allergic rhinitis (seasonal and perennial) were admitted to the trial. The treatment that was administered was: RHINAAXIA, nasal solution, applied as a double spray in each nostril, five times daily during one or two months. On the 14th day, at the first assessment, the treatment was found to have been effective or very effective (63.3% of physicians). This good result was confirmed by the later evaluations (67.8% on day 30 and 69.9% on day 60). The diary cards showed that patients who had severe symptoms at the start were greatly improved (2/3 in 4 days). In addition, good tolerance of RHINAAXIA is confirmed in this study and makes it the treatment of choice for allergic rhinitis.
D000117:Acetylglucosamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000368:Aged; D002648:Child; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005260:Female; D005944:Glucosamine / Q000031:analogs & derivatives*; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D012221:Rhinitis, Allergic, Perennial / Q000150:complications / Q000188:drug therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications / Q000188:drug therapy*; D012621:Seasons; D012996:Solutions
D000336:Aerosols; D006634:Histamine H1 Antagonists; D012996:Solutions; C036475:1-N-acetyl-2-acetamido-beta-glucopyranosylamine; D005944:Glucosamine; D000117:Acetylglucosamine
Synthèse d'une étude multicentrique réalisée au cours de la saison pollinique 1986.